+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

From
Tumor / Cancer Markers - Global Strategic Business Report - Product Thumbnail Image

Tumor / Cancer Markers - Global Strategic Business Report

  • Report
  • May 2026
  • 180 Pages
  • Global
From
From
From
From
From
From
From
From
From
CHAPLE Disease Market - Global Forecast 2025-2032 - Product Thumbnail Image

CHAPLE Disease Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 184 Pages
  • Global
From
From
Genomic Collaboration and Licensing Deals 2018-2025 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2025

  • Report
  • November 2025
  • 550 Pages
  • Global
From
From
From
Alopecia - Pipeline Review, H2 2020 - Product Thumbnail Image

Alopecia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 222 Pages
  • Global
From
Oncologists Market Report 2026 - Product Thumbnail Image

Oncologists Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator